Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Current Deferred Revenue (2016 - 2025)

Sensus Healthcare has reported Current Deferred Revenue over the past 10 years, most recently at $842000.0 for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $842000.0 for Q4 2025, up 55.64% from a year ago — trailing twelve months through Dec 2025 was $842000.0 (up 55.64% YoY), and the annual figure for FY2025 was $842000.0, up 55.64%.
  • Current Deferred Revenue for Q4 2025 was $842000.0 at Sensus Healthcare, up from $648000.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for SRTS hit a ceiling of $1.8 million in Q1 2021 and a floor of $529000.0 in Q2 2025.
  • Median Current Deferred Revenue over the past 5 years was $802500.0 (2023), compared with a mean of $937250.0.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 51.67% in 2022 and later soared 55.64% in 2025.
  • Sensus Healthcare's Current Deferred Revenue stood at $1.4 million in 2021, then tumbled by 51.67% to $693000.0 in 2022, then dropped by 5.19% to $657000.0 in 2023, then fell by 17.66% to $541000.0 in 2024, then surged by 55.64% to $842000.0 in 2025.
  • The last three reported values for Current Deferred Revenue were $842000.0 (Q4 2025), $648000.0 (Q3 2025), and $529000.0 (Q2 2025) per Business Quant data.